Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation

American Journal of Transplantation

Volumn 2, Issue 4, 2002, Pages 343-348

  Rodrigo, Emilio ^a   González Lamuño, Domingo ^a   Ruiz, Juan Carlos ^a   Fernández Fresnedo, Gema ^a   Isla, Débora ^a   González Cotorruelo, Julio ^a   Zubimendi, José Antonio ^a   De Francisco, Angel Luis Martín ^a   García Fuentes, Miguel ^a   Arias, Manuel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Apo C II polymorphism; Apo E polymorphism; Cardiovascular disease; Hyperlipidemia; Insulin resistance; Renal transplantation

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E4; CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; RISK FACTOR;

ADULT; AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 0036556218     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20409.x     Document Type: Article

References (19)

1. Kasiske BL, Guijarro C, Massy ZA et al. Cardiovascular risk after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165.
2. Wilson PW, Myers RH, Larson MG et al. Apolipoprotein E alleles, dyslipemia and coronary artery heart disease: Framingham Offspring Study. JAMA 1994; 272: 1666-1671.
3. Salas J, Jansen S, Lopez-Miranda J et al. The Sstl polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am J Clin Nutr 1998; 68: 396-401.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
5. Joint National Committee. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2445.
6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
7. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1988; 21 (S1): S5-S19.
8. Güz G, Özdemir N, Sezer S et al. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis 2000; 36: 826-836.
9. Bercedo-Sanz A, Gonzalez-Lamuho D, Malaga S, Garcia-Fuentes M. Impact of apoE4 allele on total cholesterol levels of children in northern Spain. Clin Genet 1999; 55: 69-70.
10. Roussos L, Florén CH, Carlson J, Svensson PJ, Wallmark A, Ekberg H. Increased prevalence of apolipoprotein E3/E4 genotype among Swedish renal transplant recipients. Nephron 1999; 83: 25-30.
11. De Knijff P, Johansen LG, Rosseneu M et al. Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo e and A4 polymorphisms, and lifestyle. Arterioscler Thromb 1992; 12: 1371-1379.
12. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arterioscler Thromb 1991; 11: 1237-1244.
13. Kahan BD, Ponticelli C. Cardiovascular disease and its causes. In: Kahan BD, Ponticelli C, eds. Principles and Practice of Renal Transplantation. London, UK: Martin Dunitz Ltd; 2000: pp. 589-616.
14. Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine (Baltimore) 1987; 66: 309-316.
15. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man. impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982; 54: 131-138.
16. Harris KP, Russell GI, Parvin SD, Veitch PS, Walls J. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J 1986; 292: 16.
17. Weir MR, Fink JC. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999; 34: 1-13.
18. Moller DE, Bjorbaek C, Vidal-Puig A. Candidate genes for insulin resistance. Diabetes Care 1996; 19: 396-400.
19. Waterworth DM, Ribalta J, Nicaud V, Dallongeville J, Humphries SE, Talmud P. Apo C-III gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 1999; 99: 1872-1877.